As big Pharma continues to shrink through mergers and cuts back on its R&D, it's looking to partner with academic institutions like Temple and its Moulder Center for Drug Discovery Research. Moulder Center Director Magid Abou-Gharbia expects more pharmaceutical companies to get interested in the Moulder Center’s work as its researchers, working alone and with other Temple faculty, make progress on experimental drug projects. "When you have data and intellectual property," he said, "that gets the drug companies more excited."